Modified stem cell therapy reverses new-onset Type 1 diabetes in mice

Modified stem cells reversed new-onset Type 1 diabetes in mice by reprogramming the immune system. Researchers genetically engineered mesenchymal stem cells to produce a protective protein, shielding insulin-producing cells and reducing immune attacks. This therapy aims to address the root cause of the disease. The treatment's effects persisted even after the stem cells were cleared, offering hope for long-term solutions beyond insulin injections for Type 1 diabetes.